Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



CAGNONI PABLO J Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2023 4 CAGNONI PABLO J (President, R&D) has filed a Form 4 on INCYTE CORP
Txns: Granted 179,613 shares @ $0
02/01/2023 4 CAGNONI PABLO J (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Sold 8,448 shares @ $0.25, valued at $2.1k
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Sold 6,730 shares @ $6.573, valued at $44.2k
Exercised 21,250 restricted stock units @ $0
Granted 365,000 options to buy @ $6.75, valued at $2.5M
Granted 100,000 restricted stock units @ $0
06/07/2021 4 CAGNONI PABLO J (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 17,000 options to buy @ $8.15, valued at $138.6k
02/02/2021 4 CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 375,000 options to buy @ $11.97, valued at $4.5M
Granted 85,000 restricted stock units @ $0
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2020 4 CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Bought 21,000 shares @ $4.6997, valued at $98.7k
02/03/2020 4 CAGNONI PABLO J (CEO) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 500,000 options to buy @ $7.8, valued at $3.9M
11/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2019 4 CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 15,000 options to buy @ $43.52, valued at $652.8k
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2018 4 CAGNONI PABLO J (CEO) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 164,400 options to buy @ $16.43, valued at $2.7M
Granted 193,400 options to buy @ $16.43, valued at $3.2M
07/05/2018 4 CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 5,816 shares @ $62, valued at $360.6k
Sold 1,684 shares @ $62, valued at $104.4k
Exercised 5,816 options to buy @ $5.59, valued at $32.5k
Exercised 1,684 options to buy @ $5.59, valued at $9.4k
06/15/2018 4 CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 15,000 options to buy @ $59.31, valued at $889.7k
10/20/2016 4 CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG
10/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/13/2013 4 CAGNONI PABLO J (EVP, Global R&D and Tech Ops) has filed a Form 4 on ONYX PHARMACEUTICALS INC
Txns: Granted 16,257 shares @ $0
Granted 34,030 options to buy @ $87.83, valued at $3M
10/02/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
03/20/2009 4 CAGNONI PABLO J (Sr. VP, Chief Medical Officer) has filed a Form 4 on ALLOS THERAPEUTICS INC
02/25/2009 4 CAGNONI PABLO J (Sr. VP, Chief Medical Officer) has filed a Form 4 on ALLOS THERAPEUTICS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy